FULC Financials

Fulcrum Therapeutics Inc - Financial statements & key metrics

Stock Price

$8.29

Market Cap

$552.12M

0

EPS

$-1.18

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

-

Gross Profit

-

Operating Income

-

Net Income

$-9.72M

EPS (Diluted)

$-0.16

Balance Sheet Highlights

Total Assets

$260.72M

Total Liabilities

$17.68M

Shareholders Equity

-

Cash & Equivalents

$58.21M

Total Debt

-

Cash Flow Highlights

Operating Cash Flow

$-2.22M

CapEx

-

Free Cash Flow

-

Profitability Metrics

ROE

-0.3%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is FULC revenue?

View FULC's income statement for detailed revenue data.

Is FULC profitable?

FULC reported a loss of $9.72M in the most recent quarter.

What is FULC market cap?

FULC has a market capitalization of $552.12M, making it a small-cap stock.

Does FULC have debt?

View FULC's balance sheet for debt information.

What is FULC cash flow?

Cash flow data is available in the full financial statements.

Explore Categories